Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
# Squarespace Robots Txt User-agent: AdsBot-Google Disallow: /config Disallow: /search Disallow: /account$ Disallow: /account/ Disallow: /commerce/digital-download/ Disallow: /api/ Allow: /api/ui-extensions/ Disallow: /static/ Disallow:/*?author=* Disallow:/*&author=* Disallow:/*?tag=* Disallow:/*&tag=* Disallow:/*?month=* Disallow:/*&month=* Disallow:/*?view=* Disallow:/*&view=* Disallow:/*?format=json Disallow:/*&format=json Disallow:/*?format=page-context Disallow:/*&format=page-context Disallow:/*?format=main-content Disallow:/*&format=main-content Disallow:/*?format=json-pretty Disallow:/*&format=json-pretty Disallow:/*?format=ical Disallow:/*&format=ical Disallow:/*?reversePaginate=* Disallow:/*&reversePaginate=* User-agent: AdsBot-Google-Mobile Disallow: /config Disallow: /search Disallow: /account$ Disallow: /account/ Disallow: /commerce/digital-download/ Disallow: /api/ Allow: /api/ui-extensions/ Disallow: /static/ Disallow:/*?author=* Disallow:/*&author=* Disallow:/*?tag=* |
Title | CYTIMMUNE |
Description | Targeting Solid Tumors with Combination Therapies using an Engineered Nanoparticle 0 Skip to Content About Technology Pipeline Partnering Media Contact Open Menu Close Menu About Technology Pipeline Partnering Media Contact Open Menu Clo |
Keywords | N/A |
WebSite | cytimmune.com |
Host IP | 198.49.23.144 |
Location | United States |
Site | Rank |
US$1,985,983
Last updated: 2023-05-07 07:59:53
cytimmune.com has Semrush global rank of 5,329,504. cytimmune.com has an estimated worth of US$ 1,985,983, based on its estimated Ads revenue. cytimmune.com receives approximately 229,152 unique visitors each day. Its web server is located in United States, with IP address 198.49.23.144. According to SiteAdvisor, cytimmune.com is safe to visit. |
Purchase/Sale Value | US$1,985,983 |
Daily Ads Revenue | US$1,834 |
Monthly Ads Revenue | US$54,997 |
Yearly Ads Revenue | US$659,958 |
Daily Unique Visitors | 15,277 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
cytimmune.com. | A | 900 | IP: 198.49.23.144 |
cytimmune.com. | A | 900 | IP: 198.49.23.145 |
cytimmune.com. | A | 900 | IP: 198.185.159.144 |
cytimmune.com. | A | 900 | IP: 198.185.159.145 |
cytimmune.com. | NS | 7200 | NS Record: ns75.worldnic.com. |
cytimmune.com. | NS | 7200 | NS Record: ns76.worldnic.com. |
cytimmune.com. | MX | 900 | MX Record: 10 alt3.aspmx.l.google.com. |
cytimmune.com. | MX | 900 | MX Record: 10 alt4.aspmx.l.google.com. |
cytimmune.com. | MX | 900 | MX Record: 5 alt2.aspmx.l.google.com. |
cytimmune.com. | MX | 900 | MX Record: 1 aspmx.l.google.com. |
cytimmune.com. | MX | 900 | MX Record: 5 alt1.aspmx.l.google.com. |
0 Skip to Content About Technology Pipeline Partnering Media Contact Open Menu Close Menu About Technology Pipeline Partnering Media Contact Open Menu Close Menu About Technology Pipeline Partnering Media Contact Targeting Solid Tumors with Combination Therapies using an Engineered Nanoparticle Solution Cytimmune is a phase II ready biotechnology company leading the development of next-generation nanotechnology-based cancer therapies that are capable of delivering complex biologic and enhanced small molecule drugs. Our IO+ platform enables simultaneous destruction of tumor support structures, killing of cancer cells, and activation of an anti-cancer immune response. Leadership Team Cytimmune has recently transitioned to new corporate and scientific leadership, and we are poised to rapidly advance the company’s research and clinical priorities in 2022 and beyond. Meet the team. IO+ Technology This phase 2 ready, virus-sized, engineered vector attacks solid tumors using multiple |
HTTP/1.1 301 Moved Permanently Age: 341119 Date: Sat, 23 Oct 2021 17:04:00 GMT Location: https://www.cytimmune.com/ Server: Squarespace Set-Cookie: crumb=BXSjHnmQ036xZmIyZTUzMDMxMzZmM2ExMDg3NGU3MjI4MzM0OGY4;Path=/ X-Contextid: FhAog99v/HWiCTUq5 HTTP/2 200 accept-ranges: bytes age: 347459 content-type: text/html;charset=utf-8 date: Sat, 23 Oct 2021 15:18:19 GMT etag: W/"cf4de579f2f0d31d2b5041051e61d812--gzip" expires: Thu, 01 Jan 1970 00:00:00 GMT server: Squarespace set-cookie: crumb=BUlZt73GeehtOTc4YzhlNmIwNjc4OTg4ZjYzMjIyNzczZjA4ODhj;Path=/ strict-transport-security: max-age=0 vary: Accept-Encoding x-content-type-options: nosniff x-contextid: 4K0BkGbc/6SrywwN2 |
Domain Name: CYTIMMUNE.COM Registry Domain ID: 606960_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.networksolutions.com Registrar URL: http://networksolutions.com Updated Date: 2021-09-08T01:48:44Z Creation Date: 1996-03-18T05:00:00Z Registry Expiry Date: 2022-03-19T04:00:00Z Registrar: Network Solutions, LLC Registrar IANA ID: 2 Registrar Abuse Contact Email: abuse@web.com Registrar Abuse Contact Phone: +1.8003337680 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS75.WORLDNIC.COM Name Server: NS76.WORLDNIC.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-15T12:10:15Z <<< |